Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Stephen Spencer, Managing Director at Houlihan Lokey, shares insights alongside the CEO of Capital Power on industry developments.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Scott Beiser is a Co-Chairman of Houlihan Lokey
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
"Navigating Volatility in Infrastructure Investments: Simon Brugger's Insights on Fund-of-Funds Strategies at Golding Capital Partners"
00:10:00
Silver Tiger Mines Positioned for Success Amidst Growing Silver Market
00:10:00
Navigating ARPA Fund Investments: Insights from the CWI Early Care & Education La Crosse Summit
00:10:00
Magnetic Resource: Exploring Major Gold Potential in Laverton
00:10:00
Inflation and the Fed's Response: Insights from JIC Research Edge
00:10:00
We aim to advance Catholic education in the Archdiocese of Philadelphia through innovative programs and projects initiated by Catholic schools, colleges, parishes, and religious and other Catholic-focused organizations. We provide financial support and as
00:10:00
Changing the faces of entrepreneurship|Gabby Cazeau,Principal,Harlem Capital Partners
00:10:00
Unraveling Climate Data: Transparent ESG Reporting | Sarah E. Fortt - Partner of Latham & Watkins
00:10:00
Timmins Mechanical Solutions Unveils New 12,000 Sq. Ft. Facility with Enhanced Features
00:10:00
Empowering Young Talent and Career Retraining Opportunities|Danny Rimer,investor,Index Ventures
00:10:00
Ventures on opportunities and challenges|Amit Anand,Founding Partner,Jungle Ventures
00:10:00
Transforming Financial Insights: Innovations at swissQuant Group | Dr. Florian Herzog, CEO, swissQuant Group